BG Medicine, Inc. Press Releases

BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
05/10/2013 5:04PM - GlobeNewswire

BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer
05/09/2013 7:46AM - GlobeNewswire

BG Medicine Reports 2013 First Quarter Financial Results
05/09/2013 7:45AM - GlobeNewswire

Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions
05/08/2013 7:00AM - GlobeNewswire

BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013
05/02/2013 8:30AM - GlobeNewswire

Syros Pharmaceuticals Launches with $30 Million Series A Financing
04/11/2013 12:15PM - Business Wire

BG Medicine Welcomes CE Mark for Galectin-3 Test
04/10/2013 8:18AM - GlobeNewswire

Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patients
04/10/2013 8:00AM - PR Newswire

BG Medicine Reports Fourth Quarter and Full Year 2012 Financial Results and Provides 2013 Outlook
03/13/2013 7:45AM - GlobeNewswire

BG Medicine Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiology's (ACC) 62nd Annual Scientific Session & Expo
03/06/2013 8:30AM - GlobeNewswire

BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13, 2013
03/06/2013 8:30AM - GlobeNewswire

BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients
02/27/2013 8:30AM - GlobeNewswire

BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference
02/27/2013 8:30AM - GlobeNewswire